Endocrinology and Metabolism

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

A Multicenter, Randomized, Controlled Trial for Assessing the Usefulness of Suppressing Thyroid Stimulating Hormone Target Levels after Thyroid Lobectomy in Low to Intermediate Risk Thyroid Cancer Patients (MASTER): A Study Protocol

Eun Kyung Lee, Yea Eun Kang, Young Joo Park, Bon Seok Koo, Ki-Wook Chung, Eu Jeong Ku, Ho-Ryun Won, Won Sang Yoo, Eonju Jeon, Se Hyun Paek, Yong Sang Lee, Dong Mee Lim, Yong Joon Suh, Ha Kyoung Park, Hyo-Jeong Kim, Bo Hyun Kim, Mijin Kim, Sun Wook Kim, Ka Hee Yi, Sue K. Park, Eun-Jae Jung, June Young Choi, Ja Seong Bae, Joon Hwa Hong, Kee-Hyun Nam, Young Ki Lee, Hyeong Won Yu, Sujeong Go, Young Mi Kang,

Endocrinol Metab. 2021;36(3):574-581. Published online May 26, 2021
DOI: https://doi.org/10.3803/EnM.2020.943

Is thyroid hormone supplementation avoidable for patients with low‐risk papillary thyroid cancer after thyroid lobectomy? A two‐center observational study

Liu Xiao, Jie Wu, Lisha Jiang, Yangmengyuan Xu, Bin Liu

Clinical Endocrinology. 2021;

Link1 Link2 Link3

Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid Cancer

Myung-Chul Lee, Min Joo Kim, Hoon Sung Choi, Sun Wook Cho, Guk Haeng Lee, Young Joo Park, Do Joon Park

Endocrinology and Metabolism. 2019;34(2):150

Link1 Link2 Link3

Recombinant Human Thyroid Stimulating Hormone–Assisted Radioactive Iodine Remnant Ablation in Thyroid Cancer Patients at Intermediate to High Risk of Recurrence

Jonathan Hugo, Eyal Robenshtok, Ravinder Grewal, Steve Larson, R. Michael Tuttle

Thyroid. 2012;22(10):1007-1015

Link1 Link2

The prognostic value of serum thyroid-stimulating hormone level post-lobectomy in low- and intermediate-risk papillary thyroid carcinoma

Jae Hyun Park, Yu-mi Lee, Yi Ho Lee, Suck Joon Hong, Jong Ho Yoon

Journal of Surgical Oncology. 2018;

Link1 Link2

Thyroid Stimulating Hormone Suppression and Recurrence After Thyroid Lobectomy For Papillary Thyroid Carcinoma

Mi Rye Bae, Sung Hoon Nam, Jong-Lyel Roh, Seung-Ho Choi, Soon Yuhl Nam, Sang Yoon Kim

. 2021;

Link1 Link2

Initiation of Thyroid Hormone Replacement Is Common Following Thyroid Lobectomy for Low-Risk Differentiated Thyroid Cancer

Maria Papaleontiou

Clinical Thyroidology. 2021;33(6):281-284

Link1 Link2

Age-Related Serum Thyroid-Stimulating Hormone Reference Range in Older Patients Treated with Levothyroxine: A Randomized Controlled Feasibility Trial (SORTED 1)

Salman Razvi, Vicky Ryan, Lorna Ingoe, Simon H. Pearce, Scott Wilkes

European Thyroid Journal. 2019;9(1):40-48

Link1 Link2

Ultrasound-Guided Radiofrequency Ablation Versus Thyroid Lobectomy for Low-Risk Papillary Thyroid Microcarcinoma: A Propensity-Matched Cohort Study of 884 Patients

Lin Yan, Mingbo Zhang, Qing Song, Yukun Luo

Thyroid. 2021;

Link1 Link2

The Recovery of Thyroid Function in Low-Risk Papillary Thyroid Cancer After Lobectomy: A 3-Year Follow-Up Study

Yi Dou, Yingji Chen, Daixing Hu, Xinliang Su

Frontiers in Endocrinology. 2021;11:

Link1

Thyroid-Stimulating Hormone and Thyroid-Stimulating Hormone Receptor

Stéphanie Gaillard, Fredric E. Wondisford

Clinical Management of Thyroid Disease. 2009;81-101

Link1 Link2